Transgender Women's Barriers, Facilitators, and Preferences on Tailored Injection Delivery Strategies to Administer Long-Acting Injectable Cabotegravir (CAB-LA) for HIV Pre-exposure Prophylaxis (PrEP).
AIDS Behav
; 25(12): 4180-4192, 2021 Dec.
Article
in En
| MEDLINE
| ID: mdl-34216284
Full text:
1
Database:
MEDLINE
Main subject:
HIV Infections
/
Anti-HIV Agents
/
Transgender Persons
/
Pre-Exposure Prophylaxis
Type of study:
Guideline
/
Qualitative_research
Limits:
Female
/
Humans
Language:
En
Journal:
AIDS Behav
Journal subject:
CIENCIAS DO COMPORTAMENTO
/
SINDROME DA IMUNODEFICIENCIA ADQUIRIDA (AIDS)
Year:
2021
Type:
Article
Affiliation country:
United States